Moderna and BioNTech’s share prices have increased by 621% and 237% year-to-date. Is it too late to get in on these COVID-19 vaccine frontrunners?

The pandemic may have stunted the growth of numerous businesses, but here are three that continue to have great long-term prospects.

Will technology stocks remain relevant in the brave new world?

The US dollar, which is also known as the greenback, has been coming on and off the boil since the start of the year. Mostly, it has been off.

Stock markets are rallying as an end may be in sight for this brutal pandemic.

Despite lingering concerns over the demand for office space, we believe these three commercial REITs should continue to do well.